Growth Hormone Injection for Idiopathic Short Stature in Children
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be prepubertal (boys age 3 to under 11 with testicles less than 4 mL; girls age 3 to under 10 with no breast development).
- Your child's height must be at least 2 standard deviations below average for their age and sex (very short compared to peers).
- Your child must have a growth hormone stimulation test showing a peak level of at least 10 ng/mL (to rule out growth hormone deficiency).
- Your child must not have taken growth hormone or similar medications for growth before (for 1 month or more).
- Your child must not have any other known cause for short stature (like Turner syndrome, Noonan syndrome, or thyroid problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
This trial tests an investigational drug called GenSci134 for children with idiopathic short stature (short height with no known cause). It aims to see if the drug can help them grow taller. The study is for children who have not been treated with growth hormones before.
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
This trial tests a medication called vosoritide to see if it can help children with unexplained short stature grow taller. It's for kids who are very short for their age but have normal growth hormone levels and no other known cause.
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
Hear when a new Idiopathic Short Stature trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.